Keros Therapeutics (KROS) Moves 9.8% Higher: Will This Strength Last?

Keros Therapeutics, Inc. (KROS) shares ended the last trading session 9.8% higher at $15.19. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock's 11.1% loss over the past four weeks.The stock price gain can be attributed to investor optimism regarding the potential of Keros’ pipeline candidate, KER-065, being developed for treating neuromuscular disorders, with an initial focus on Duchenne muscular dystrophy in a phase ...